These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 37244011)
1. Translatability barriers between preclinical and clinical trials of AAV gene therapy in inherited retinal diseases. Shamshad A; Kang C; Jenny LA; Persad-Paisley EM; Tsang SH Vision Res; 2023 Sep; 210():108258. PubMed ID: 37244011 [TBL] [Abstract][Full Text] [Related]
2. Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications. Schön C; Biel M; Michalakis S Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):343-52. PubMed ID: 25615882 [TBL] [Abstract][Full Text] [Related]
3. AAV-mediated gene therapy for retinal disorders: from mouse to man. Buch PK; Bainbridge JW; Ali RR Gene Ther; 2008 Jun; 15(11):849-57. PubMed ID: 18418417 [TBL] [Abstract][Full Text] [Related]
4. AAV-mediated gene therapy for retinal disorders in large animal models. Stieger K; Lhériteau E; Moullier P; Rolling F ILAR J; 2009; 50(2):206-24. PubMed ID: 19293463 [TBL] [Abstract][Full Text] [Related]
5. Gene therapy for inherited retinal diseases: progress and possibilities. Hu ML; Edwards TL; O'Hare F; Hickey DG; Wang JH; Liu Z; Ayton LN Clin Exp Optom; 2021 May; 104(4):444-454. PubMed ID: 33689657 [TBL] [Abstract][Full Text] [Related]
6. Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients. Colella P; Auricchio A Hum Gene Ther; 2012 Aug; 23(8):796-807. PubMed ID: 22734691 [TBL] [Abstract][Full Text] [Related]
7. Adeno-Associated Viral Vectors as a Tool for Large Gene Delivery to the Retina. Trapani I Genes (Basel); 2019 Apr; 10(4):. PubMed ID: 30970639 [TBL] [Abstract][Full Text] [Related]
12. Clinical Pharmacology Perspective on Development of Adeno-Associated Virus Vector-Based Retina Gene Therapy. Ford JL; Karatza E; Mody H; Nagaraja Shastri P; Khajeh Pour S; Yang TY; Swanson M; Chao D; Devineni D Clin Pharmacol Ther; 2024 Jun; 115(6):1212-1232. PubMed ID: 38450707 [TBL] [Abstract][Full Text] [Related]
13. Advances in AAV vector development for gene therapy in the retina. Day TP; Byrne LC; Schaffer DV; Flannery JG Adv Exp Med Biol; 2014; 801():687-93. PubMed ID: 24664759 [TBL] [Abstract][Full Text] [Related]
14. AAV-mediated gene therapy in mouse models of recessive retinal degeneration. Pang JJ; Lei L; Dai X; Shi W; Liu X; Dinculescu A; McDowell JH Curr Mol Med; 2012 Mar; 12(3):316-30. PubMed ID: 22300136 [TBL] [Abstract][Full Text] [Related]
15. Risk Mitigation of Immunogenicity: A Key to Personalized Retinal Gene Therapy. Varin J; Morival C; Maillard N; Adjali O; Cronin T Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884622 [TBL] [Abstract][Full Text] [Related]
16. Versatility of AAV vectors for retinal gene transfer. Surace EM; Auricchio A Vision Res; 2008 Feb; 48(3):353-9. PubMed ID: 17923143 [TBL] [Abstract][Full Text] [Related]
17. A novel adeno-associated viral variant for efficient and selective intravitreal transduction of rat Müller cells. Klimczak RR; Koerber JT; Dalkara D; Flannery JG; Schaffer DV PLoS One; 2009 Oct; 4(10):e7467. PubMed ID: 19826483 [TBL] [Abstract][Full Text] [Related]
18. Human Retinal Explant Culture for Ex Vivo Validation of AAV Gene Therapy. Orlans HO; Edwards TL; De Silva SR; Patrício MI; MacLaren RE Methods Mol Biol; 2018; 1715():289-303. PubMed ID: 29188522 [TBL] [Abstract][Full Text] [Related]
19. Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates. Kotterman MA; Yin L; Strazzeri JM; Flannery JG; Merigan WH; Schaffer DV Gene Ther; 2015 Feb; 22(2):116-26. PubMed ID: 25503696 [TBL] [Abstract][Full Text] [Related]